NCT04503044View on ClinicalTrials.gov

ILAs in CT Lung Cancer Screening Population

CompletedOBSERVATIONAL
Enrollment

1,703

Participants

Timeline

Start Date

January 30, 2021

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions
Interstitial Lung DiseaseIPF
Interventions
OTHER

Retrospective observational study

No intervention to occur

Trial Locations (1)

01805

Lahey Hospital and Medical Center, Burlington

Sponsors

Lead Sponsor

Lahey Clinic

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

Lahey Clinic

OTHER